Micro-Dystrophin Gene Therapy Reveals Hidden Immune Storm in Treated Boys
A proteomic study of the phase 1/2a delandistrogene moxeparvovec trial shows that high-dose AAV gene therapy triggers a sharp but ...
A proteomic study of the phase 1/2a delandistrogene moxeparvovec trial shows that high-dose AAV gene therapy triggers a sharp but ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine